Key facts
- This page summarizes David P. Meeker's Form 4 filing for Trevi Therapeutics, Inc. (TRVI).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 29 Aug 2024, 16:55.
David P. Meeker - 27 Aug 2024 Form 4 Insider Report for Trevi Therapeutics, Inc. (TRVI)
- Reporting relationship
- Director
- Issuer ticker
- TRVI
- Reported as of
- 27 Aug 2024
- Net transaction value
- -$6,839
- SEC form
- 4
- Accepted by SEC
- 29 Aug 2024, 16:55:24 UTC
- Prior SEC filing
- 14 Jun 2024
- Next SEC filing
- 04 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher Galletta, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David P. Meeker filed Form 4 for Trevi Therapeutics, Inc. (TRVI) on 29 Aug 2024.
Change
- Previous filing in this sequence was filed on 14 Jun 2024.
- Current net transaction value: -$6,839.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TRVI
transaction
Common Stock
Options Exercise
- Transaction value
- $6,514
- Shares
- +4,555
- Change %
- +1.3%
- Price
- $1.43
- Shares after
- 357,044
- Date
- 27 Aug 2024
- Ownership
- Direct
TRVI
transaction
Common Stock
Sale
- Transaction value
- $13,353
- Shares
- -4,555
- Change %
- -1.3%
- Price
- $2.93
- Shares after
- 352,489
- Date
- 27 Aug 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TRVI
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -4,555
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 27 Aug 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,555
- Exercise price
- $1.43
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.9100 to $2.9500 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Footnote F2
This option was granted on November 25, 2014. The 4,555 shares of common stock underlying the option vested as to 25% of the shares on November 25, 2015 and vested as to the remaining 75% of the shares in equal quarterly installments thereafter through November 25, 2018.